Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes have?
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes has 1,325 citations in the OpenAlex counts ScholarIQ stores.
When was Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes published?
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes has 2012 year in the ScholarIQ index.
What is the open-access status of Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes?
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes?
The DOI for Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes is on the source record.
What is the PMID of Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes?
The PMID for Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes is on the source record.
What is the OpenAlex record for Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes?
The OpenAlex for Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes is on the source record.